Positive MOG Test? Why Your MS Diagnosis May Need Review

Credibility

Interest

Share:2 min read

Key Takeaway

A positive MOG antibody test does not rule out MS, so people with signs of both conditions may need follow-up to get the right diagnosis and care.

What They Found

Researchers studied 78 adults who had a clearly positive MOG antibody blood test and at least one sign that can suggest MS. MOG antibodies are proteins made by the immune system that can point to a different condition called MOGAD, which can look like MS. About 1 in 4 people in the study were classified as having typical MS, while the diagnosis remained unclear for the others. In the typical MS group, 28% had another attack of symptoms and 55% developed new spots on brain or spinal cord scans during follow-up. In the unclear group, some scan spots disappeared completely, showing that changes over time can offer important clues.

Who Should Care and Why

This matters most to people whose symptoms or scans suggest MS but whose blood test is positive for MOG antibodies. A positive test is one piece of the puzzle, not a final answer by itself. If this describes you, ask your specialist what supports your diagnosis and whether follow-up scans could help clarify it. Caregivers can help by keeping a record of new symptoms, attacks, and scan results to discuss at visits. Getting the diagnosis right matters because it helps the care team decide whether and when to use ongoing treatment.

Important Considerations

This was a small study that looked back at patient records, so it cannot show which treatment works best or whether delaying treatment caused later changes. Many people still had an unclear diagnosis, even after follow-up. Do not change or stop treatment based on a blood test alone; review the full picture with your MS specialist.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Early Research Treatment Updates

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurology(R) neuroimmunology & neuroinflammation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News